ftInvstr
SHALBY · Healthcare ₹152.51 +0.38% Mkt Cap ₹1613 Cr

SHALBY

Healthcare Medical Care Facilities
₹152.51
+0.38% today · 30d -6.89%
as of 2026-09-04
Price · Daily Candles
“SHALBY's Profitability Plummets 97.72%, Despite Revenue Growth, as DIIs Edge Up Stake”
SHALBY, a Medical Care Facilities provider, recorded a significant annual net profit decline of -97.72% for the fiscal year ending March 2025, despite an annual revenue growth of 14.03% to ₹1087 Cr. The company's TTM PE ratio stands at a high 223.0, contrasting with a subdued ROE of 0.35% and ROCE of 6.0%.
BULL CASE
+Annual revenue for Shalby grew by 14.03% year-over-year to ₹1087 Cr for the fiscal year ending March 2025.
+The 1-month price return is 13.4%, and the 1-week return is 7.6%, suggesting recent positive momentum.
+The company's 3-year revenue CAGR is 15.86% and 5-year revenue CAGR is 17.43%, indicating consistent top-line growth over the longer term.
+DIIs slightly increased their stake by 0.05% QoQ, reaching 0.25% as of March 2026.
BEAR CASE
Net profit for the fiscal year ending March 2025 collapsed by -97.72% YoY to ₹2 Cr.
Quarterly net profit was substantially low at ₹1.0 Cr for Q4 2025, with a -1.27% YoY decline in revenue.
The TTM PE ratio is 223.0, and ROCE is only 6.0%, indicating a stretched valuation relative to profitability.
The stock is trading -35.77% off its 52-week high of ₹274.7.
FIIs decreased their stake by -0.11% QoQ, holding 4.36% as of March 2026.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹331 Cr
+11.74% YoY
NET PROFIT
₹10 Cr
+36.7% YoY
OPM
14.47%
-1.53pp YoY
EPS
₹0.98
PE 223.0
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-9.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
SHALBY's TTM PE of 223.0 and ROCE of 6.0% place it as a high-valuation, low-efficiency outlier compared to peers like APOLLOHOSP (PE 82.13, ROCE 20.26%) and NH (PE 47.68, ROCE 22.72%).
PEERPEROCE %
SHALBY223.06.0
APOLLOHOSP82.1320.26
MAXHEALTH67.0714.44
FORTIS94.2613.4
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
34
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth STEADY 69
Profitability AVERAGE 42
Technicals WEAK 40
Risk ELEVATED 30
Key Stats
TTM PE
223.0
P/B
1.88
52W HIGH
₹274.7
OFF HIGH
-44.48%
MKT CAP
₹1613 Cr
◉ Active Signals
MACDNeutral0.1476
RSI(14)Bearish39.87
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SHALBY and at what entry.

Sign up freeSign in